Foghorn Therapeutics Inc. (FHTX)
2.01
-0.03 (1.47%)
Upcoming Events
Latest Headlines
Evercore ISI Downgrades Foghorn Therapeutics (FHTX) to In Line
October 13, 2026 2:38 AM - StreetInsider
Form 3 Foghorn Therapeutics For: Oct 01 Filed by: BVF II GP LLC
October 5, 2026 4:28 PM - SEC Filing
Form SCHEDULE 13G/A Foghorn Therapeutics Filed by: BIOTECHNOLOGY VALUE FUND L P
October 5, 2026 4:27 PM - SEC Filing
Foghorn Therapeutics (FHTX) PT Lowered to $5 at H.C. Wainwright
October 2, 2026 6:54 AM - StreetInsider
Wedbush Downgrades Foghorn Therapeutics (FHTX) to Neutral
October 2, 2026 6:47 AM - StreetInsider
Foghorn Therapeutics (FHTX) PT Lowered to $5 at Guggenheim
October 2, 2026 6:45 AM - StreetInsider
BTIG Downgrades Foghorn Therapeutics (FHTX) to Neutral
October 1, 2026 4:38 PM - StreetInsider
TD Cowen Downgrades Foghorn Therapeutics (FHTX) to Hold
October 1, 2026 4:08 PM - StreetInsider
Citizens Downgrades Foghorn Therapeutics (FHTX) to Market Perform
October 1, 2026 2:55 PM - StreetInsider
Foghorn Therapeutics (FHTX) PT Lowered to $5 at Stifel
October 1, 2026 12:44 PM - StreetInsider
Foghorn cuts 40% of staff after FHD-909 trial falls short
October 1, 2026 7:02 AM - StreetInsider
Form 8-K Foghorn Therapeutics For: Sep 25
October 1, 2026 7:01 AM - SEC Filing
Foghorn Therapeutics Provides Update on FHD-909 and Strategic Priorities
October 1, 2026 7:00 AM - StreetInsider
Citizens Reiterates Market Outperform Rating on Foghorn Therapeutics (FHTX) Ahead of Ph1 Results
September 17, 2026 4:10 AM - StreetInsider
Foghorn Therapeutics (FHTX) Reiterated at Buy by Stifel Amid Early Pipeline Excitement
August 17, 2026 7:10 AM - StreetInsider
Foghorn Therapeutics Inc. (FHTX) Tops Q2 EPS by 15c
August 6, 2026 8:02 AM - StreetInsider
Form 10-Q Foghorn Therapeutics For: Jun 30
August 6, 2026 7:03 AM - SEC Filing
Form 8-K Foghorn Therapeutics For: Aug 06
August 6, 2026 7:02 AM - SEC Filing
Foghorn Therapeutics Provides Second Quarter 2026 Financial and Corporate Update
August 6, 2026 7:01 AM - StreetInsider
Full Article List
